CHANGE IN RATINGS
rated new Overweight at Morgan Stanley. $32 price target. Market is underestimating the company's international expansion potential.
Church & Dwight
rated new Equal-weight at Morgan Stanley. $64 price target. Company has strong business momentum, though there's competitive risk in the laundry business.
( CHTT) rated new Equal-weight at Morgan Stanley. $69 price target. Stock is inexpensive, but the company is facing weak sales at non-core brands. Private-label pressure also persists.
( CKR) upgraded at Credit Suisse from Neutral to Outperform. $12 price target. Company trades at a discount to its peers. Estimates should also increase, to reflect more stable comp sales.
rated new Equal-weight at Morgan Stanley. $74 price target. Growth prospects are toward the low end of the market.
( GYMB) numbers boosted at FBR to $46. Estimates also increased, to reflect growth at the Crazy 8 division. Market Perform rating.
Jack In The Box
( JBX) upgraded at JP Morgan. Rating raised to Overweight from Neutral. Price target raised to $24 from $23. Maintains 2009 EPS estimates of $2.10.
upgraded at KeyBanc. Rating raised to Buy from Hold. Introduces $23 price target. Raises 2009 EPS estimates to $0.58 from $0.53.
( ME) rated new Outperform at Credit Suisse. $16 price target. Company has an established track record and does not over-spend for the sake of higher growth.
rated new Equal-weight at Morgan Stanley. $16 price target. Company could have a strong second half of the year but upside will likely be limited in 2010.
rated new Overweight at Barclays. $180 price target. Company is growing 2-3 times faster than its largest competitor, with the core expansion coming from outside of the U.S.
downgraded at Credit Suisse from Outperform to Neutral. $21 price target. Company is seeing margins fall, as the sales mix shifts away from hard goods.
estimates cut at Barclays through 2011. Inflation benefit is disappearing and hardgoods sales aren't bouncing back as quickly as expected. Equal-weight rating and $20 price target.
upgraded at Friedman, Billings Ramsey from Market Perform to Outperform. $60 price target. Company is the strongest performer in a recent credit analysis.
downgraded at Deutsche Bank. Rating lowered to Hold from Buy. Maintains $5 price target and 2009 EPS estimates of -$1.12.
rated new Overweight at Morgan Stanley. $44 price target. Business mix has shifted toward high-growth emerging markets.
downgraded at KeyBanc. Rating lowered to Underweight from Hold. Introduces $20 price target. Maintains 2009 EPS estimates of $0.83.
rated new Underweight at Morgan Stanley. $24 price target. Company seeing lower demand and a shrinking market for its food.
STOCK COMMENTS / EPS CHANGES
numbers boosted at Goldman. Estimates were increased through 2013. Company should benefit from the Carefusion spin. Neutral rating and new $36 price target.
estimates, target raised at Goldman. Shares now seen reaching $47. Estimates also boosted, to reflect cost controls and a better outlook for Deere Capital. Neutral rating.
2009 estimates reduced at Merrill/BofA to reflect high compensation costs. Company also seeing a higher tax rate and share count. Buy rating and $32 price target.
estimates cut at Merrill/BofA through 2011. Chinese pricing is falling. Buy rating and $180 price target.
added to Conviction Buy list at Goldman. Valuation call, as spending should increase in Europe. Buy rating and new $560 price target.
target raised at Goldman to $23. Company had a strong quarter, but lacks significant operating leverage. Neutral rating.
estimates lowered at Barclays through 2011. Storage market is stabilizing, but season pressures remain. Equal-weight rating and $25 price target.
estimates raised at Barclays through 2010. Demand is more stable and margins could improve because of lower inventory levels. Overweight rating and $38 price target.
target raised at Merrill/BofA to $18. Company has strong order momentum. Neutral rating.
This article was written by a staff member of TheStreet.com.